Lt. Gen. Michael McCurry, commanding general of U.S. Army Futures and Concepts Command, gives a speech during command's activation ceremony at Joint Base Langley-Eustis, Virginia, Feb. 12, 2026.

The Army shuttered its largest command on Friday to activate in its place a new organization focused on soldiers’ efforts in the Western Hemisphere as the service continues a major shakeup of its top ...

Researchers from MIT, Northeastern University, and Meta recently released a paper suggesting that large language models (LLMs) similar to those that power ChatGPT may sometimes prioritize sentence ...

This file analyses AQoL-6D Adolescent instrument data and produces a utility score for the instrument overall and a score for each dimension. Missing values: Note that missing values are represented ...

Human language is based on syntax, a complex set of rules about how words can be combined. In theory, the emergence of syntactic communication might have been a comparatively straightforward process.

U.S. Army paratroopers assigned to the 173rd Airborne Brigade prepare to operate a First Person View (FPV) drone at Pabradė Training Area, Lithuania, May 2025. (Sgt. Jose Lora/Army) AUSTIN, Texas — ...

The Army Training and Doctrine Command cased its flag Friday at Joint Base Langley-Eustis, Va., to close out 52 years of building the framework that shapes soldiers to fight on the ever-evolving ...

Add Task & Purpose (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

U.S. Army Col. Christopher J. Kirkpatrick receives the Joint Multinational Readiness Center colors from Brig. Gen. Steven P. Carpenter during a Change of Command Ceremony near Hohenfels, Germany, Aug.

Background: Adverse childhood experiences (ACEs) have been identified as a risk factor for the development of mental health and behavioural outcomes throughout life, including delinquent behaviours.

CHICAGO--(BUSINESS WIRE)--Syntax Bio, a preclinical-stage biotechnology company, has launched with backing from Astellas Venture Management LLC and Illumina Ventures. Other investors include DCVCBio, ...